• October 17, 2019
    • Loading stock data...
  • Europe Just Approved First CBD Oil, Paves the Way for Sizable Growth

    LinkedIn
    1. PALM BEACH, Florida, Sept. 26, 2019/PRNewswire/ — The European market is on course to grow 400% over the next four years, according to the Brightfield Group. Better, European regulators just approved GW Pharmaceuticals’ Epidyolex – the first CBD oil to gain approval in Europe.  “The approval of cannabidiol oral solution is an important milestone for patients and families whose lives are significantly impacted by these rare, complex and life-long forms of epilepsy,” said Isabella Brambilla, Chairman of the Dravet Syndrome European Federation. “We are very happy that patients will now have access to a much-needed, new treatment option, and one routed through a rigorous clinical trials program and licensed by the EMA.”  As Europe wakes up to the CBD opportunity, it’s opening a wide range of opportunity for cannabis companies that have already established launching cannabis products including The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF),  Charlotte’sWeb Holdings Inc. (CSE:CWEB) (OTCQX:CWBHF), Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB), Canopy Growth Corporation (TSX:WEED) (NYSE:CGC), and Aphria Inc. (NYSE:APHA) (TSX:APHA).

    Source: https://www.prnewswire.com/news-releases/europe-just-approved-first-cbd-oil-paves-the-way-for-sizable-growth-300925775.html

    Share.

    About Author

    Comments are closed.